Pancreatic Cysts - Guidelines Based Management

AdventHealth

V. Shami

How Recent Data Impacts Pancreatic Cancer Management

Integrity CE

M. Pishvaian

ESMO 2024 Summary: Updates in Pancreatic Cancer and Impacts on Pract…

2024 ESMO Annual Meeting Insights Hub

H. Babiker

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

E. Dotan

ESMO 2024 Summary: Latest Advances in Targeted Therapies for Pancrea…

2024 ESMO Annual Meeting Insights Hub

D. Melisi

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Cancer Screening Molecular Tools

Fengting Yan

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Cancers

UChicago Medicine Annual Practice Updates in Hematology and Oncology

M. Amin

Updates in Perioperative Therapy of Pancreatic Cancer

Horizon CME

P. Philip

ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinical Ut…

2024 ASCO® Annual Meeting Insights Hub

S. Cohen

NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …

Yale Cancer Center

J. Lacy

Targeting KRAS in Pancreatic Cancer

Harshabad Singh

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Pancreatic Adenocarcinoma and Neuroendocrine Tumors - An Update

AdventHealth

M. Tejani

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Integrity CE

W. Burns

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX v…

ecancer

J. Knox